Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation.

PMID: 20621801
Journal: JOURNAL OF THE NEUROLOGICAL SCIENCES
Year: 2010
Reference: J Neurol Sci. 2010 Aug 15;295(1-2):110-3. Epub 2010 Jun 8.
Impact factor: 2.324
Publication type: Paper in international publication
Authors: Urbizu, Aintzane, Cuenca-Leon, Ester, Raspall-Chaure, Miquel, Gratacos, Margarida, Conill, Joan, Redecillas, Susana, Roig-Quilis, Manuel, Macaya, Alfons et al.
DOI: 10.1016/j.jns.2010.05.017

Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation.

PMID: 20621801
Journal: JOURNAL OF THE NEUROLOGICAL SCIENCES
Year: 2010
Reference: J Neurol Sci. 2010 Aug 15;295(1-2):110-3. Epub 2010 Jun 8.
Impact factor:
Publication type: Paper in international publication
Authors: Conill, Joan; Cuenca-Leon, Ester; Gratacos, Margarida; Macaya, Alfons; Raspall-Chaure, Miquel; Redecillas, Susana; Roig-Quilis, Manuel; Urbizu, Aintzane et al.
DOI: 10.1016/j.jns.2010.05.017

Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.

PMID: 19897463
Journal: JOURNAL OF MEDICAL GENETICS
Year: 2010
Reference: J Med Genet. 2010 May;47(5):312-20. Epub 2009 Nov 5.
Impact factor: 5.751
Publication type: Paper in international publication
Authors: Antonell, A, Del Campo, M, Magano, L F, Kaufmann, L, de la Iglesia, J Martinez, Gallastegui, F, Flores, R, Schweigmann, U, Fauth, C, Kotzot, D et al.
DOI: 10.1136/jmg.2009.071712

Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.

PMID: 19897463
Journal: JOURNAL OF MEDICAL GENETICS
Year: 2010
Reference: J Med Genet. 2010 May;47(5):312-20. Epub 2009 Nov 5.
Impact factor:
Publication type: Paper in international publication
Authors: Antonell, A; de la Iglesia, J Martinez; Del Campo, M; Fauth, C; Flores, R; Gallastegui, F; Kaufmann, L; Kotzot, D; Magano, L F; Perez-Jurado, L A et al.
DOI: 10.1136/jmg.2009.071712

Pathogenic lysosomal depletion in Parkinson's disease.

PMID: 20844148
Journal: JOURNAL OF NEUROSCIENCE
Year: 2010
Reference: J Neurosci. 2010 Sep 15;30(37):12535-44.
Impact factor: 7.178
Publication type: Paper in international publication
Authors: Dehay, Benjamin, Bove, Jordi, Rodriguez-Muela, Natalia, Perier, Celine, Recasens, Ariadna, Boya, Patricia, Vila, Miquel et al.
DOI: 10.1523/JNEUROSCI.1920-10.2010

Pathogenic lysosomal depletion in Parkinson's disease.

PMID: 20844148
Journal: JOURNAL OF NEUROSCIENCE
Year: 2010
Reference: J Neurosci. 2010 Sep 15;30(37):12535-44.
Impact factor:
Publication type: Paper in international publication
Authors: Bove, Jordi; Boya, Patricia; Dehay, Benjamin; Perier, Celine; Recasens, Ariadna; Rodriguez-Muela, Natalia; Vila, Miquel et al.
DOI: 10.1523/JNEUROSCI.1920-10.2010

Pathology of the thoracic wall: congenital and acquired.

PMID: 20432004
Journal: PEDIATRIC RADIOLOGY
Year: 2010
Reference: Pediatr Radiol. 2010 Jun;40(6):859-68. doi: 10.1007/s00247-010-1604-z. Epub 2010 Apr 30.
Impact factor: 1.186
Publication type: Review in international publication
Authors: Garcia-Pena, Pilar, Barber, Ignasi et al.
DOI: 10.1007/s00247-010-1604-z

Pathology of the thoracic wall: congenital and acquired.

PMID: 20432004
Journal: PEDIATRIC RADIOLOGY
Year: 2010
Reference: Pediatr Radiol. 2010 Jun;40(6):859-68. doi: 10.1007/s00247-010-1604-z. Epub 2010 Apr 30.
Impact factor:
Publication type: Review in international publication
Authors: Barber, Ignasi; Garcia-Pena, Pilar et al.
DOI: 10.1007/s00247-010-1604-z

[Pathophysiology of CADASIL disease]

PMID: 20036399
Journal: MEDICINA CLINICA
Year: 2010
Reference: Med Clin (Barc). 2010 Jul 10;135(5):222-30. Epub 2009 Dec 29.
Impact factor: 1.231
Publication type: Review in national publication
Authors: Del Rio Espinola, Alberto, Sole, Esther, Montaner, Joan et al.
DOI: 10.1016/j.medcli.2009.10.034

[Pathophysiology of CADASIL disease]

PMID: 20036399
Journal: MEDICINA CLINICA
Year: 2010
Reference: Med Clin (Barc). 2010 Jul 10;135(5):222-30. Epub 2009 Dec 29.
Impact factor:
Publication type: Review in national publication
Authors: Del Rio Espinola, Alberto; Montaner, Joan; Sole, Esther et al.
DOI: 10.1016/j.medcli.2009.10.034

Patients with spina bifida and bladder cancer. Our experience

PMID: NOPMID038
Journal: Cerebrospinal Fluid Research
Year: 2010
Reference: Patients with spina bifida and bladder cancer. Our experience. Cerebrospinal Fluid Res. 2010; 7(s1):s54
Impact factor: 0
Publication type: Paper in international publication
Authors: Pages Bolibar, Esther, Montesinos Magraner, Lluisa, Melendez Plumed, Mar, Rodriguez Gonzalez, Susana, Cuxart Fina, Maria Amparo et al.
DOI: 10.1186/1743-8454-7-S1-S54

Patients with spina bifida and bladder cancer. Our experience

PMID: NOPMID038
Journal: Cerebrospinal Fluid Research
Year: 2010
Reference: Patients with spina bifida and bladder cancer. Our experience. Cerebrospinal Fluid Res. 2010; 7(s1):s54
Impact factor:
Publication type: Paper in international publication
Authors: Cuxart Fina, Maria Amparo; Melendez Plumed, Mar; Montesinos Magraner, Lluisa; Pages Bolibar, Esther; Rodriguez Gonzalez, Susana et al.
DOI: 10.1186/1743-8454-7-S1-S54

Pattern of Response of National Institutes of Health Stroke Scale Components to Early Recanalization in the CLOTBUST Trial.

PMID: 20133918
Journal: STROKE
Year: 2010
Reference: Stroke. 2010 Mar;41(3):466-70. Epub 2010 Feb 4.
Impact factor: 7.041
Publication type: Paper in international publication
Authors: , , , , , , , et al.
DOI: 10.1161/STROKEAHA.109.567263

Pattern of Response of National Institutes of Health Stroke Scale Components to Early Recanalization in the CLOTBUST Trial.

PMID: 20133918
Journal: STROKE
Year: 2010
Reference: Stroke. 2010 Mar;41(3):466-70. Epub 2010 Feb 4.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; et al.
DOI: 10.1161/STROKEAHA.109.567263

Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study.

PMID: 20100964
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2010
Reference: J Clin Oncol. 2010 Mar 1;28(7):1181-9. Epub 2010 Jan 25.
Impact factor: 17.793
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1200/JCO.2009.22.6043

Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study.

PMID: 20100964
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2010
Reference: J Clin Oncol. 2010 Mar 1;28(7):1181-9. Epub 2010 Jan 25.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1200/JCO.2009.22.6043

Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors.

PMID: 20805299
Journal: CLINICAL CANCER RESEARCH
Year: 2010
Reference: Clin Cancer Res. 2010 Oct 1;16(19):4876-83. Epub 2010 Aug 30.
Impact factor: 6.747
Publication type: Paper in international publication
Authors: Baselga, Jose, Cervantes, Andres, Martinelli, Erika, Chirivella, Isabel, Hoekman, Klaas, Hurwitz, Herbert I, Jodrell, Duncan I, Hamberg, Paul, Casado, Esther, Elvin, Paul et al.
DOI: 10.1158/1078-0432.CCR-10-0748

Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors.

PMID: 20805299
Journal: CLINICAL CANCER RESEARCH
Year: 2010
Reference: Clin Cancer Res. 2010 Oct 1;16(19):4876-83. Epub 2010 Aug 30.
Impact factor:
Publication type: Paper in international publication
Authors: Baselga, Jose; Casado, Esther; Cervantes, Andres; Chirivella, Isabel; Elvin, Paul; Hamberg, Paul; Hoekman, Klaas; Hurwitz, Herbert I; Iacona, Renee; Jodrell, Duncan I et al.
DOI: 10.1158/1078-0432.CCR-10-0748

Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics.

PMID: 20724522
Journal: MOLECULAR CANCER THERAPEUTICS
Year: 2010
Reference: Mol Cancer Ther. 2010 Oct;9(10):2844-52. Epub 2010 Aug 19.
Impact factor: 4.953
Publication type: Paper in international publication
Authors: Eton, Omar, Fingert, Howard, Tabernero, Josep, Liu, Hua, Bowman, Douglas, Chakravarty, Arijit, Shinde, Vaishali, Cervantes, Andres, Elez, Elena, Rodriguez-Braun, Edith et al.
DOI: 10.1158/1535-7163.MCT-10-0299

Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics.

PMID: 20724522
Journal: MOLECULAR CANCER THERAPEUTICS
Year: 2010
Reference: Mol Cancer Ther. 2010 Oct;9(10):2844-52. Epub 2010 Aug 19.
Impact factor:
Publication type: Paper in international publication
Authors: Baselga, Jose; Blasco, Inma; Bowman, Douglas; Cervantes, Andres; Chakravarty, Arijit; Danaee, Hadi; Ecsedy, Jeffrey; Elez, Elena; Eton, Omar; Fingert, Howard et al.
DOI: 10.1158/1535-7163.MCT-10-0299

Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non-Small-Cell Lung Cancer.

PMID: 20516450
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2010
Reference: J Clin Oncol. 2010 Jul 1;28(19):3131-7. Epub 2010 Jun 1.
Impact factor: 17.793
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1200/JCO.2009.23.9749

Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non-Small-Cell Lung Cancer.

PMID: 20516450
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2010
Reference: J Clin Oncol. 2010 Jul 1;28(19):3131-7. Epub 2010 Jun 1.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1200/JCO.2009.23.9749

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.

PMID: 20028707
Journal: MULTIPLE SCLEROSIS
Year: 2010
Reference: Mult Scler. 2010 Feb;16(2):197-207. Epub 2009 Dec 22.
Impact factor: 3.279
Publication type: Paper in international publication
Authors: Kappos, L, Comi, G, O'Connor, P, Montalban, X, Antel, J, Radue, E-W, Karlsson, G, Pohlmann, H, Aradhye, S, Kappos, L et al.
DOI: 10.1177/1352458509357065

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.

PMID: 20028707
Journal: MULTIPLE SCLEROSIS
Year: 2010
Reference: Mult Scler. 2010 Feb;16(2):197-207. Epub 2009 Dec 22.
Impact factor:
Publication type: Paper in international publication
Authors: Achtnichts, L; Airas, L; Almeida, M; Antel, J; Antel, J; Antel, J; Aradhye, S; Arbizu, T; Arroyo, R; Baldini, S et al.
DOI: 10.1177/1352458509357065

Publications

Publications searcher

Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation.

Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation.

Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.

Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.

Pathogenic lysosomal depletion in Parkinson's disease.

Pathogenic lysosomal depletion in Parkinson's disease.

Pathology of the thoracic wall: congenital and acquired.

Pathology of the thoracic wall: congenital and acquired.

[Pathophysiology of CADASIL disease]

[Pathophysiology of CADASIL disease]

Patients with spina bifida and bladder cancer. Our experience

Patients with spina bifida and bladder cancer. Our experience

Pattern of Response of National Institutes of Health Stroke Scale Components to Early Recanalization in the CLOTBUST Trial.

Pattern of Response of National Institutes of Health Stroke Scale Components to Early Recanalization in the CLOTBUST Trial.

Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study.

Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study.

Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors.

Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors.

Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics.

Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics.

Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non-Small-Cell Lung Cancer.

Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non-Small-Cell Lung Cancer.

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.

Patronage:

Collaborating:

Accreditations: